Kristen A Muñoz

Facilitating Compound Entry as a Means to Discover Antibiotics for Gram-Negative Bacteria.

P. Hergenrother, Kristen A Muñoz, 2021, Accounts of chemical research.

Computational discovery of dynobactin antibiotics

P. Hergenrother, Kristen A Muñoz, 2022, Nature Microbiology.

An Iterative Approach Guides Discovery of the FabI Inhibitor Fabimycin, a Late-Stage Antibiotic Candidate with In Vivo Efficacy against Drug-Resistant Gram-Negative Infections

Angela M. Zaino, D. Caridha, P. Hergenrother, 2022, ACS central science.

A Gram-negative-selective antibiotic that spares the gut microbiome.

Christopher J. Fields, Jessica R. Holmes, P. Hergenrother, 2024, Nature.